Mohd Ashhad: Cryoprecipitate – A Small Blood Component with a Big Clinical Role
Mohd Ashhad, Assistant at Blood bank, shared a post on LinkedIn:
“Cryoprecipitate: A Small Blood Component with a Big Clinical Role
In transfusion medicine, every blood component has a specific purpose.
Cryoprecipitate is a plasma-derived blood component that plays an important role in managing certain bleeding conditions.
What is Cryoprecipitate?
Cryoprecipitate is prepared by thawing Fresh Frozen Plasma (FFP) at cold temperatures and collecting the precipitated proteins. It is then refrozen for storage.
What does Cryoprecipitate contain?
It is rich in:
- Fibrinogen (Factor I)
- Factor VIII
- von Willebrand Factor (vWF)
- Factor XIII
- Fibronectin
When is it used?
Cryoprecipitate may be transfused when there is significant hypofibrinogenemia or dysfibrinogenemia, particularly in situations such as:
- Massive hemorrhage
- Major trauma or surgery with low fibrinogen
- Disseminated Intravascular Coagulation (DIC) with bleeding
- Certain congenital fibrinogen disorders
Important point:
Cryoprecipitate should not be used simply as a source of Factor VIII or vWF when specific factor concentrates are available and appropriate.
Its use should be guided by clinical condition and laboratory results, especially fibrinogen levels.
From donor to patient, every component matters.
Proper preparation, storage, identification, compatibility procedures, and transfusion practices are essential for patient safety.
As laboratory professionals and blood bank technologists, understanding the preparation, contents, indications, and quality requirements of cryoprecipitate is an important part of transfusion medicine.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems